The Law of Informational Capitalism von KAPCZYNSKI, AMY

Volltext

Federal Trade Commission Oversight of the Pharmaceutical Industry von Kapczynski, JD, Amy

Volltext

Order without intellectual property law: Open science in influenza von Kapczynski, Amy

Volltext

Harmonization and Its Discontents: A Case Study of TRIPS Implementation in India's Pharmaceutical Sector von Kapczynski, Amy

Volltext

Building a Law-and-Political-Economy Framework: Beyond the Twentieth-Century Synthesis von BRITTON-PURDY, JEDEDIAH, GREWAL, DAVID SINGH, KAPCZYNSKI, AMY, RAHMAN, K. SABEEL

Volltext

Polymorphs and prodrugs and salts (oh my!): an empirical analysis of "secondary" pharmaceutical patents von Kapczynski, Amy, Park, Chan, Sampat, Bhaven

Volltext

The big data regulator, rebooted: Why and how the FDA can and should disclose confidential data on prescription drugs and vaccines von Morten, Christopher J., Kapczynski, Amy

Volltext

Rethinking Law von Kapczynski, Amy

Volltext

The Political Economy of Market Power in Pharmaceuticals von Kapczynski, Amy

Volltext

Innovation Sticks: The Limited Case for Penalizing Failures to Innovate von Ayres, Ian, Kapczynski, Amy

Volltext

THE LOCHNERIZED FIRST AMENDMENT AND THE FDA: TOWARD A MORE DEMOCRATIC POLITICAL ECONOMY RESPONSE TO THE COLUMBIA LAW REVIEW’S 2018 SYMPOSIUM von Kapczynski, Amy

Volltext

Realizing Public Rights Through Government Patent Use von Kapczynski, Amy

Volltext

The Trans-Pacific Partnership — Is It Bad for Your Health? von Kapczynski, Amy

Volltext

Free Speech and Pharmaceutical Regulation—Fishy Business von Kapczynski, Amy

Volltext

The Access to Knowledge Mobilization and the New Politics of Intellectual Property von Kapczynski, Amy

Volltext

Engineered in India — Patent Law 2.0 von Kapczynski, Amy

Volltext

The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism von Kapczynski, Amy

Volltext

THE LOCHNERIZED FIRST AMENDMENT AND THE FDA: TOWARD A MORE DEMOCRATIC POLITICAL ECONOMY von Kapczynski, Amy

Volltext

Promotion of Drugs for Off-label Uses: The US Food and Drug Administration at a Crossroads von Kim, Jeanie, Kapczynski, Amy

Volltext

Is Bayh-Dole good for developing countries? Lessons from the US experience von So, Anthony D, Sampat, Bhaven N, Rai, Arti K, Cook-Deegan, Robert, Reichman, Jerome H, Weissman, Robert, Kapczynski, Amy

Volltext